1. Home
  2. UUU vs OSRH Comparison

UUU vs OSRH Comparison

Compare UUU & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UUU
  • OSRH
  • Stock Information
  • Founded
  • UUU 1969
  • OSRH N/A
  • Country
  • UUU United States
  • OSRH United States
  • Employees
  • UUU N/A
  • OSRH N/A
  • Industry
  • UUU Electronic Components
  • OSRH
  • Sector
  • UUU Technology
  • OSRH
  • Exchange
  • UUU Nasdaq
  • OSRH Nasdaq
  • Market Cap
  • UUU 12.6M
  • OSRH 13.2M
  • IPO Year
  • UUU N/A
  • OSRH N/A
  • Fundamental
  • Price
  • UUU $4.38
  • OSRH $0.65
  • Analyst Decision
  • UUU
  • OSRH
  • Analyst Count
  • UUU 0
  • OSRH 0
  • Target Price
  • UUU N/A
  • OSRH N/A
  • AVG Volume (30 Days)
  • UUU 111.7K
  • OSRH 3.4M
  • Earning Date
  • UUU 11-19-2025
  • OSRH 11-24-2025
  • Dividend Yield
  • UUU 22.42%
  • OSRH N/A
  • EPS Growth
  • UUU N/A
  • OSRH N/A
  • EPS
  • UUU 1.19
  • OSRH N/A
  • Revenue
  • UUU $22,789,285.00
  • OSRH $104,735.00
  • Revenue This Year
  • UUU N/A
  • OSRH N/A
  • Revenue Next Year
  • UUU N/A
  • OSRH N/A
  • P/E Ratio
  • UUU $3.96
  • OSRH N/A
  • Revenue Growth
  • UUU 30.84
  • OSRH N/A
  • 52 Week Low
  • UUU $1.65
  • OSRH $0.45
  • 52 Week High
  • UUU $8.27
  • OSRH $13.40
  • Technical
  • Relative Strength Index (RSI)
  • UUU 43.68
  • OSRH 52.44
  • Support Level
  • UUU $4.30
  • OSRH $0.59
  • Resistance Level
  • UUU $4.80
  • OSRH $0.82
  • Average True Range (ATR)
  • UUU 0.50
  • OSRH 0.11
  • MACD
  • UUU -0.08
  • OSRH 0.00
  • Stochastic Oscillator
  • UUU 4.79
  • OSRH 28.00

About UUU Universal Security Instruments Inc.

Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.

About OSRH OSR Holdings Inc. Common Stock

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: